TC
ISEE

TFS Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

TFS Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,002
Closed -$766K – 1045
2016
Q2 		$766K Sell
15,002
-29,918
-67% -$1.49M 0.14% 243
2016
Q1 		$1.9M Buy
+44,920
New +$2.29M 0.27% 79
2015
Q4 		– Sell
-10,635
Closed -$431K – 948
2015
Q3 		$431K Sell
10,635
-5,844
-35% -$310K 0.04% 564
2015
Q2 		$858K Buy
+16,479
New +$820K 0.08% 378
2014
Q1 		– Sell
-8,394
Closed -$272K – 1636
2013
Q4 		$272K Buy
+8,394
New +$249K 0.01% 1142

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TFS Capital's ISEE Position: Q3 2016 in Review

TFS Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2016, closing a stake of 15,002 shares — an estimated $766K sold.

TFS Capital first reported a position in ISEE in Q4 2013 and held it in 5 quarters. The position peaked at $1.9M in Q1 2016. 191 funds tracked by Wall St. Rank hold ISEE as of Q3 2016.

  • TFS Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • TFS Capital sold 15,002 IVERIC bio, Inc. Common Stock shares in Q3 2016, an estimated $766K.
  • TFS Capital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 5 quarters.
  • TFS Capital's IVERIC bio, Inc. Common Stock position peaked at $1.9M in Q1 2016.
  • 191 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2016.

Based on TFS Capital's 13F filing for Q3 2016, filed 10 Nov 2016.